Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 2/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | COMT | P21964 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | METAP1 | P53582 | 1/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.47 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | PLAU | P00749 | 1/20 | 0.42 |
| ▸ | NCF1 | P14598 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28754132 | 0.98 | METAP2 (0.53) | METAP2MMP2CHRM1TSHRCOMT | |
| Thiourea SCHEMBL3241360 | 0.91 | METAP2 (0.47) | METAP2MMP2CHRM1TSHRCOMT | |
| Quinazoline SCHEMBL561027 | 0.89 | EGFR (0.67) | METAP2MMP2CHRM1TSHRCOMT | |
| SCHEMBL11798326 | 0.87 | TSHR (0.51) | METAP2MMP2CHRM1TSHRCOMT | |
| Trifluoroacetic Acid SCHEMBL29618258 | 0.85 | PAX8 (0.56) | METAP2MMP2CHRM1TSHRCOMT | |
| Trifluoroacetic Acid SCHEMBL29618251 | 0.85 | PAX8 (0.56) | METAP2MMP2CHRM1TSHRCOMT | |
| SCHEMBL27527609 | 0.83 | EGFR (0.44) | METAP2MMP2CHRM1TSHRCOMT | |
| SCHEMBL12747762 | 0.79 | EGFR (0.47) | METAP2MMP2CHRM1TSHRCOMT | |
| SCHEMBL3074807 | 0.78 | EGFR (0.50) | MMP2TSHRKDM4EEGFRALDH1A1 | |
| SCHEMBL559673 | 0.77 | EGFR (0.48) | KDM4EEGFRCYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118239931-A | As P2X3Aminoquinazoline derivatives of inhibitors | 奇斯药制品公司 | 2024-06-25 | — | — | CN | claimed |
| CN-114269432-B | As P2X3Aminoquinazoline derivatives of inhibitors | 奇斯药制品公司 | 2024-05-07 | — | — | CN | claimed |
| CN-114269432-A | As P2X3Aminoquinazoline derivatives as inhibitors | 奇斯药制品公司 | 2022-04-01 | — | — | CN | claimed |
| EP-2493956-B1 | MOISTURE-CURING FORMULATIONS WITH TIME-MODIFIED CURING BEHAVIOR | HENKEL AG & CO KGAA (DE) | 2018-04-18 | — | — | EP | claimed |
| WO-2016154694-A1 | N-ACYLHYDRAZONE COMPOUNDS INHIBITING HISTONE DESACETYLASE ENZYMES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHOD FOR PRODUCING SAME | UNIVERSIDADE FEDERAL DO RIO DE JANEIRO-UFRJ (BR) | 2016-10-06 | — | — | WO | claimed |
| EP-3074482-A1 | ENCODED CHROMOPHORIC POLYMER PARTICLES | University Of Washington Through Its Center For Commercialization (US) | 2016-10-05 | — | — | EP | claimed |
| CN-102712751-B | Moisture-curing formulations with time-modified phases | HENKEL AG & CO KGAA | 2015-06-10 | — | — | CN | claimed |
| WO-2015081126-A1 | ENCODED CHROMOPHORIC POLYMER PARTICLES | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2015-06-04 | — | — | WO | claimed |
| US-8592517-B2 | Moisture-curing formulations with time-modified phases | HENKEL AG & CO. KGAA (DE) | 2013-11-26 | — | — | US | claimed |
| US-20120277373-A1 | MOISTURE-CURING FORMULATIONS WITH TIME-MODIFIED PHASES | HENKEL AG & CO. KGAA (DE) | 2012-11-01 | — | — | US | claimed |
| EP-1558585-A4 | NEUROLOGICALLY-ACTIVE COMPOUNDS | PRANA BIOTECHNOLOGY LTD (AU) | 2008-07-02 | — | — | EP | claimed |
| CN-1720238-A | Neurologically-active compounds | PRANA BIOTECHNOLOGY LTD (AU) | 2006-01-11 | — | — | CN | claimed |
| EP-1558585-A1 | NEUROLOGICALLY-ACTIVE COMPOUNDS | Prana Biotechnology Ltd (AU) | 2005-08-03 | — | — | EP | claimed |
| WO-2004031161-A1 | NEUROLOGICALLY-ACTIVE COMPOUNDS | PRANA BIOTECHNOLOGY LIMITED (AU) | 2004-04-15 | — | — | WO | claimed |
| US-5385990-A | Blend of epoxy compound, amine hardener and hydroxy substituted aromatic compound | LORD CORPORATION (US) | 1995-01-31 | — | — | US | claimed |
| CN-1087367-A | Structural adhesive composition with high temperature resistance | LORD CORP (US) | 1994-06-01 | — | — | CN | claimed |
| EP-0596622-A2 | Epoxy resin structural adhesive composition having high temperature resistance | LORD CORPORATION (US) | 1994-05-11 | — | — | EP | claimed |
| EP-0377357-B1 | Process for the condensation of at least one epoxide on at least one cyclic anhyhride in the presence of a titanium-based catalyst | INST FRANCAIS DU PETROLE (FR) | 1994-03-23 | — | — | EP | claimed |
| US-5183919-A | Process for the preparation of diaryl carbonates | THE DOW CHEMICAL COMPANY (US) | 1993-02-02 | — | — | US | claimed |
| US-4714614-A | PSEUDOMONAS AND FERRIC ION CHELATING AGENT | COLORADO STATE UNIVERSITY (US) | 1987-12-22 | — | — | US | claimed |